Skip to main content
Equibles

Suzanne Balberhuizen

Analyst

Van Lanschot Kempen

Equibles does not estimate personal net worth.

About Suzanne Balberhuizen

Suzanne Balberhuizen is recorded as Analyst at Van Lanschot Kempen. Suzanne Balberhuizen has spoken on 1 earnings call across 1 company, most recently for Genmab A/S on February 17, 2026. The companies whose calls Suzanne Balberhuizen spoke on are classified in the Healthcare sector.

Suzanne Balberhuizen on recent calls

“I was wondering for Pito whether we should be expecting a Phase 1-2 data update in head and neck cancer during this year at a medical conference, considering especially the frontline data set for the matured since ASCO last year.”
Analyst — Van Lanschot Kempen, Genmab A/S Q4 FY2025 Earnings Call ·

Affiliation history

  • Van Lanschot Kempen

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity